These results suggest that Src and IGF-1R regulate overlapping pathways and their combined inhibition may be more effective than inhibiting either kinase alone in treating PCa cells, especially when IGF-1 is abundant, such as in bone metastases. The gene discussed is SRC; the disease is posterior cortical atrophy.